Open AccessThe effects of medication on intraocular pressure in children with attention deficit hyperactivity disorder: A prospective study
Author(s) -
Oğuz Güvenmez,
Mehmet Özgür Çubuk,
Serkan Güneş
Publication year - 2020
Publication title -
canadian journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.166
H-Index - 40
ISSN - 1710-6222
DOI - 10.15586/jptcp.v27i2.665
Subject(s) - methylphenidate , atomoxetine , attention deficit hyperactivity disorder , medicine , intraocular pressure , psychiatry , child and adolescent psychiatry , pediatrics
Attention deficit hyperactivity disorder (ADHD) is one of the most common psychiatric conditions in childhood. Psychopharmacological therapy is an effective treatment for ADHD. In this study, we primarily aim to investigate the effects of psychopharmacological agents on intraocular pressure (IOP) in children with ADHD. The sample included 82 children with ADHD and 36 healthy children aged between 8 and 12 years who were referred to the Department of Child and Adolescent Psychiatry in Hatay State Hospital, Hatay, Turkey. Children with ADHD were divided into two groups according to the medication used: methylphenidate (MPH) group and atomoxetine (ATX) group. Before treatment and after 1- and 6-month treatment period, IOP was measured by Goldmann applanation tonometry. There were no statistical differences in terms of age, gender, and IOP between the three groups (P > 0.05). After 1- and 6-month treatment, the IOP did not change significantly between baseline and 1 month or 6 months (P > 0.05). Children with ADHD may have an IOP similar to healthy children. Six-month treatment with MPH or ATX may not cause significant changes in IOP.